A detailed history of Neville Rodie & Shaw Inc transactions in Pfizer Inc stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 96,563 shares of PFE stock, worth $2.87 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
96,563
Previous 139,461 30.76%
Holding current value
$2.87 Million
Previous $3.87 Million 30.18%
% of portfolio
0.21%
Previous 0.3%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 01, 2024

SELL
$25.26 - $29.6 $1.08 Million - $1.27 Million
-42,898 Reduced 30.76%
96,563 $2.7 Million
Q1 2024

Apr 09, 2024

SELL
$25.89 - $29.73 $242,874 - $278,897
-9,381 Reduced 6.3%
139,461 $3.87 Million
Q4 2023

Jan 02, 2024

SELL
$26.13 - $33.94 $180,845 - $234,898
-6,921 Reduced 4.44%
148,842 $4.29 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $8,086 - $9,452
-252 Reduced 0.16%
155,763 $5.17 Million
Q2 2023

Jul 06, 2023

SELL
$36.12 - $41.79 $54,721 - $63,311
-1,515 Reduced 0.96%
156,015 $5.72 Million
Q1 2023

Apr 04, 2023

BUY
$39.39 - $51.28 $106,904 - $139,173
2,714 Added 1.75%
157,530 $6.43 Million
Q4 2022

Jan 03, 2023

BUY
$41.75 - $54.5 $292,250 - $381,500
7,000 Added 4.74%
154,816 $7.93 Million
Q3 2022

Oct 04, 2022

SELL
$43.76 - $53.42 $389,332 - $475,277
-8,897 Reduced 5.68%
147,816 $6.47 Million
Q4 2021

Jan 05, 2022

SELL
$41.32 - $61.25 $89,747 - $133,035
-2,172 Reduced 1.37%
156,713 $9.25 Million
Q3 2021

Oct 06, 2021

SELL
$39.25 - $50.42 $25,355 - $32,571
-646 Reduced 0.4%
158,885 $6.83 Million
Q2 2021

Jul 06, 2021

BUY
$35.91 - $40.68 $5,961 - $6,752
166 Added 0.1%
159,531 $6.25 Million
Q1 2021

Apr 08, 2021

BUY
$33.49 - $37.77 $170,799 - $192,627
5,100 Added 3.31%
159,365 $5.77 Million
Q4 2020

Mar 04, 2021

SELL
$33.47 - $42.56 $14,224 - $18,088
-425 Reduced 0.27%
154,265 $5.68 Million
Q3 2020

Oct 01, 2020

SELL
$31.75 - $37.25 $34,925 - $40,975
-1,100 Reduced 0.71%
154,690 $5.68 Million
Q2 2020

Jul 15, 2020

SELL
$30.12 - $36.54 $29,065 - $35,261
-965 Reduced 0.62%
155,790 $5.09 Million
Q1 2020

Apr 01, 2020

SELL
$27.03 - $38.62 $193,399 - $276,326
-7,155 Reduced 4.37%
156,755 $5.12 Million
Q4 2019

Jan 08, 2020

SELL
$32.92 - $37.36 $312,740 - $354,920
-9,500 Reduced 5.48%
163,910 $6.42 Million
Q3 2019

Oct 02, 2019

SELL
$32.49 - $42.13 $294,814 - $382,287
-9,074 Reduced 4.97%
173,410 $6.23 Million
Q2 2019

Jul 01, 2019

SELL
$36.98 - $41.52 $83,205 - $93,420
-2,250 Reduced 1.22%
182,484 $7.91 Million
Q1 2019

Apr 08, 2019

SELL
$37.5 - $41.2 $150,525 - $165,376
-4,014 Reduced 2.13%
184,734 $7.85 Million
Q4 2018

Jan 03, 2019

BUY
$38.47 - $43.86 $4,847 - $5,526
126 Added 0.07%
188,748 $8.24 Million
Q3 2018

Oct 09, 2018

SELL
$34.47 - $41.81 $199,064 - $241,452
-5,775 Reduced 2.97%
188,622 $8.31 Million
Q2 2018

Jul 03, 2018

SELL
$32.98 - $35.16 $32,980 - $35,160
-1,000 Reduced 0.51%
194,397 $7.05 Million
Q1 2018

Apr 12, 2018

SELL
$31.91 - $37.02 $20,230 - $23,470
-634 Reduced 0.32%
195,397 $6.93 Million
Q4 2017

Jan 03, 2018

BUY
$33.26 - $35.29 $31,596 - $33,525
950 Added 0.49%
196,031 $7.1 Million
Q3 2017

Oct 03, 2017

BUY
$31.0 - $34.15 $6.05 Million - $6.66 Million
195,081
195,081 $6.97 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.